Biohealth sector regulation and market access in Singapore

Previous Next

Context:

Singapore continues to represent one of the fastest growing markets among developed countries in Asia in the overall medical devices and technologies sector. Singapore’s medical devices market is expected to grow at a CAGR of 6.5% between 2021 and 2026, resulting in a market close to €1 billion by 2026. In addition to the domestic market, Singapore will continue to strengthen its position as a distribution hub for the region thanks to its strategic location, not only geographically, but also in terms of infrastructure, government incentives and the ease of doing business in the country.

Factors such as a high value-added manufacturing and supply chain and technology content, a strong R&D ecosystem and being a hub for innovation in new business models and technology have attracted more than 60 multinational companies in the sector to set up their production or distribution activities in Singapore.

Objective:

Basque Trade & Investment, Trade Promotion Agency of the Basque Country Government, through our office in Singapore and in collaboration with Enterprise SG, is organizing a webinar on Biohealth sector regulation and market access in Singapore.

The objective of this webinar is to increase the knowledge among Basque companies in the certification process in Singapore, as well as describe market access strategies, recommendations, etc.

Target audience:

Medtech companies from the Basque Country.